365 related articles for article (PubMed ID: 32563057)
1. Therapeutic anti-psoriatic effects of myeloid-derived suppressor cells in combination with systemic tacrolimus (FK-506) in an imiquimod-induced mouse model of psoriasis.
Park MY; Choo YK; Jeon SH; Jang WG; Lee JH; Park JH; Kim CH
Int Immunopharmacol; 2020 Sep; 86():106553. PubMed ID: 32563057
[TBL] [Abstract][Full Text] [Related]
2. Anti-psoriatic effect of myeloid-derived suppressor cells on imiquimod-induced skin inflammation in mice.
Kim CH; Yoo JK; Jeon SH; Lim CY; Lee JH; Koo DB; Park MY
Scand J Immunol; 2019 Mar; 89(3):e12742. PubMed ID: 30548969
[TBL] [Abstract][Full Text] [Related]
3. Protective effects of agonistic anti-4-1BB antibody on the development of imiquimod-induced psoriasis-like dermatitis in mice.
Yoo JK; Choo YK; Kwak DH; Lee JM; Lim CY; Lee JH; Park MY; Kim CH
Immunol Lett; 2016 Oct; 178():131-9. PubMed ID: 27592361
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory Effect of Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice by Histamine H4 Receptor Agonist 4-Methylhistamine.
Kim CH; Lee JM; Yoo JK; Kim JS; Kim SU; Chang KT; Choo YK
Scand J Immunol; 2016 Jun; 83(6):409-17. PubMed ID: 26900758
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic and immunomodulatory effects of glucosamine in combination with low-dose cyclosporine a in a murine model of imiquimod-induced psoriasis.
Kim CH; Kim JY; Lee AY
Eur J Pharmacol; 2015 Jun; 756():43-51. PubMed ID: 25796200
[TBL] [Abstract][Full Text] [Related]
6. Multi-glycoside of Tripterygium wilfordii Hook. f. ameliorates imiquimod-induced skin lesions through a STAT3-dependent mechanism involving the inhibition of Th17-mediated inflammatory responses.
Zhao J; Di T; Wang Y; Liu X; Liang D; Zhang G; Li P
Int J Mol Med; 2016 Sep; 38(3):747-57. PubMed ID: 27431437
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of interleukin-2-inducible T-cell kinase causes reduction in imiquimod-induced psoriasiform inflammation through reduction of Th17 cells and enhancement of Treg cells in mice.
Nadeem A; Ahmad SF; Al-Harbi NO; Ibrahim KE; Alqahtani F; As Sobeai HM; Alotaibi MR
Biochimie; 2020 Dec; 179():146-156. PubMed ID: 33007409
[TBL] [Abstract][Full Text] [Related]
8. Effect of γ-secretase inhibitor on Th17 cell differentiation and function of mouse psoriasis-like skin inflammation.
Ma L; Xue H; Qi R; Wang Y; Yuan L
J Transl Med; 2018 Mar; 16(1):59. PubMed ID: 29523162
[TBL] [Abstract][Full Text] [Related]
9. Calcipotriol and betamethasone dipropionate exhibit different immunomodulatory effects on imiquimod-induced murine psoriasiform dermatitis.
Takeoka S; Shimizu T; Kamata M; Hau CS; Fukaya S; Hayashi K; Fukuyasu A; Tanaka T; Ishikawa T; Ohnishi T; Tada Y
J Dermatol; 2020 Feb; 47(2):155-162. PubMed ID: 31762070
[TBL] [Abstract][Full Text] [Related]
10. Combination Therapy of Acarbose and Cyclosporine a Ameliorates Imiquimod-Induced Psoriasis-Like Dermatitis in Mice.
Chen HH; Lin CC; Tung YT; Chao YH; Huang WC; Lee PY
Molecules; 2020 Apr; 25(8):. PubMed ID: 32316255
[TBL] [Abstract][Full Text] [Related]
11. Oral administration of acarbose ameliorates imiquimod-induced psoriasis-like dermatitis in a mouse model.
Chen HH; Chao YH; Chen DY; Yang DH; Chung TW; Li YR; Lin CC
Int Immunopharmacol; 2016 Apr; 33():70-82. PubMed ID: 26874324
[TBL] [Abstract][Full Text] [Related]
12. Worsening of imiquimod-induced psoriasiform inflammation in mice by environmental pollutant, di-(2-ethylhexyl) phthalate through dysregulation in IL-17A and Nrf2/iNOS signaling in peripheral myeloid and CD4 + T cells.
Alfardan AS; Nadeem A; Ahmad SF; Al-Harbi NO; Alqinyah M; Attia SM; Sarawi W; Alanazi AZ; Alhazzani K; Ibrahim KE
Int Immunopharmacol; 2024 Jan; 126():111293. PubMed ID: 38056199
[TBL] [Abstract][Full Text] [Related]
13. Kaempferol attenuates imiquimod-induced psoriatic skin inflammation in a mouse model.
Liu C; Liu H; Lu C; Deng J; Yan Y; Chen H; Wang Y; Liang CL; Wei J; Han L; Dai Z
Clin Exp Immunol; 2019 Dec; 198(3):403-415. PubMed ID: 31407330
[TBL] [Abstract][Full Text] [Related]
14. CXCL17 Attenuates Imiquimod-Induced Psoriasis-like Skin Inflammation by Recruiting Myeloid-Derived Suppressor Cells and Regulatory T Cells.
Oka T; Sugaya M; Takahashi N; Takahashi T; Shibata S; Miyagaki T; Asano Y; Sato S
J Immunol; 2017 May; 198(10):3897-3908. PubMed ID: 28389593
[TBL] [Abstract][Full Text] [Related]
15. Hispidulin alleviates imiquimod-induced psoriasis-like skin inflammation by inhibiting splenic Th1/Th17 cell population and keratinocyte activation.
Kim N; Lee S; Kang J; Choi YA; Lee B; Kwon TK; Jang YH; Kim SH
Int Immunopharmacol; 2020 Oct; 87():106767. PubMed ID: 32679548
[TBL] [Abstract][Full Text] [Related]
16. Decreased expression of IL-27 in moderate-to-severe psoriasis and its anti-inflammation role in imiquimod-induced psoriasis-like mouse model.
Chen W; Gong Y; Zhang X; Tong Y; Wang X; Fei C; Xu H; Yu Q; Wang Y; Shi Y
J Dermatol Sci; 2017 Feb; 85(2):115-123. PubMed ID: 27939414
[TBL] [Abstract][Full Text] [Related]
17. Azithromycin impairs TLR7 signaling in dendritic cells and improves the severity of imiquimod-induced psoriasis-like skin inflammation in mice.
Huang SW; Chen YJ; Wang ST; Ho LW; Kao JK; Narita M; Takahashi M; Wu CY; Cheng HY; Shieh JJ
J Dermatol Sci; 2016 Oct; 84(1):59-70. PubMed ID: 27449383
[TBL] [Abstract][Full Text] [Related]
18. Targeting Myeloid-Derived Suppressor Cells Is a Novel Strategy for Anti-Psoriasis Therapy.
Chen C; Tan L; Zhu W; Lei L; Kuang Y; Liu P; Li J; Chen X; Peng C
Mediators Inflamm; 2020; 2020():8567320. PubMed ID: 32684837
[TBL] [Abstract][Full Text] [Related]
19. Effects of Topical Application of Betamethasone on Imiquimod-induced Psoriasis-like Skin Inflammation in Mice.
Mori H; Arita K; Yamaguchi T; Hirai M; Kurebayashi Y
Kobe J Med Sci; 2016 Sep; 62(4):E79-E88. PubMed ID: 28239073
[TBL] [Abstract][Full Text] [Related]
20. Anti-psoriasis effect of water-processed rosin in mice.
Li XQ; Chen Y; Zhou HM; Shi HL; Yan XN; Lin LP; Tan RX
J Ethnopharmacol; 2019 Oct; 242():112073. PubMed ID: 31288049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]